Palmieri C, Musson A, Harper-Wynne C, Wheatley D, et al. A real-world study of the first use of palbociclib for the treatment of advanced breast cancer within the UK National Health Service as part of the novel Ibrance(R) Patient Program. Br J Cancer 2023 Jul 19. doi: 10.1038/s41416-023-02352.
PMID: 37468569